This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Central Garden (CENT) Up 3.7% Since Last Earnings Report?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
V.F. Corp (VFC) Falls 7% as Q4 Earnings & Sales Miss Estimates
by Zacks Equity Research
V.F. Corp's (VFC) fourth-quarter fiscal 2020 results bear the brunt of the lower demand due to the coronavirus pandemic. The company withholds guidance for fiscal 2021 on prevailing uncertainty.
Central Garden's (CENT) Q2 Earnings & Sales Beat Estimates
by Zacks Equity Research
Central Garden & Pet's (CENT) Q2 results benefit from acquisition-related gains, lower costs and solid growth in the Pet Segment. However, it withdraws fiscal 2020 view on COVID-19 impacts.
Prestige Consumer (PBH) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Prestige Consumer's (PBH) fourth-quarter fiscal 2020 results reflect solid consumption trends at core brands in the domestic regions and strong international unit performance.
Central Garden (CENT) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 2.63% and 1.45%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Factors Shaping Up Central Garden & Pet's (CENT) Q2 Earnings
by Zacks Equity Research
Central Garden & Pet's (CENT) second-quarter fiscal 2020 performance has most likely been aided by higher organic sales and contributions from acquisitions.
Spectrum Brands' (SPB) Q2 Earnings & Sales Beat Estimates
by Zacks Equity Research
Spectrum Brands' (SPB) Q2 results gain from lower costs, operating income growth and contributions from the global productivity improvement plan. It withdraws fiscal 2020 view due to COVID-19 impacts.
What Makes Central Garden (CENT) a New Buy Stock
by Zacks Equity Research
Central Garden (CENT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Central Garden (CENT) to Report Q2 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Central Garden (CENT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Skechers (SKX) Beats on Q1 Earnings, Coronavirus Hampers Sales
by Zacks Equity Research
Skechers (SKX) looks forward to reopening stores globally. Also, the company continues to invest in its e-commerce platform.
Wolverine's (WWW) Q1 Earnings Beat Despite Coronavirus Woes
by Zacks Equity Research
Wolverine (WWW) first-quarter 2020 revenues were hurt by coronavirus. The bottom line also declined year over year.
Snap-on's (SNA) Q1 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
Weaker sales, currency headwinds and challenging economic conditions stemming from the COVID-19 crisis dented Snap-on's (SNA) Q1 results.
Central Garden (CENT) Down 10% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Central Garden (CENT) Q1 Loss Lower Than Estimated, Sales Top
by Zacks Equity Research
Central Garden's (CENT) reports a narrower-than-expected loss for first-quarter fiscal 2020.
Central Garden (CENT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 33.33% and 2.23%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
How Central Garden & Pet (CENT) Looks Ahead of Q1 Earnings
by Zacks Equity Research
Central Garden & Pet's (CENT) first-quarter fiscal 2020 bottom line is likely to reflect higher SG&A costs and weakness in animal health businesses.
Earnings Preview: Central Garden (CENT) Q1 Earnings Expected to Decline
by Zacks Equity Research
Central Garden (CENT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Central Garden (CENT) Stock is Losing Momentum
by Zacks Equity Research
Central Garden (CENT) is grappling with high SG&A trend, which may affect the bottom line in the near term. Also, softness in the Pet segment's animal health businesses remains a concern.
New Strong Sell Stocks for November 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Company News for Nov 29, 2019
by Zacks Equity Research
Companies In The News Are: CENT, BOX, DPLO, EVH
Central Garden (CENT) Q4 Earnings Lag Estimates, Sales Beat
by Zacks Equity Research
Central Garden's (CENT) bottom-line results for the fiscal fourth quarter fail to impress. It expects to incur first-quarter fiscal 2020 loss of 10-15 cents on softness in the animal health businesses.
Central Garden & Pet (CENT) to Post Q4 Earnings: What Awaits?
by Zacks Equity Research
Central Garden & Pet (CENT) fourth-quarter fiscal 2019 results are expected to reflect strength in the Garden segment. Also, the company's solid pricing actions bode well.
Central Garden & Pet to Gain From Buyouts & Growth Efforts
by Zacks Equity Research
Although rising costs remains a woe for Central Garden (CENT), solid garden segment and recent buyouts are likely to drive growth in the long-run.
Utilize New Analyst Coverage to Find Strong Stocks in September
by Benjamin Rains
One way to find solid investments with potential for big returns amid the current market conditions is to search for stocks that more analysts have started to cover recently...
Why Is Central Garden (CENT) Down 1% Since Last Earnings Report?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.